Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by James Baumann
Prospective Surveillance Study of Haemophilia a Patients Switching From Moroctocog Alfa or Other Factor VIII Products to Moroctocog Alfa Albumin-Free Cell Culture (AF-CC) in Usual Care Settings
Thrombosis and Haemostasis
Hematology
Related publications
Postmarketing Safety and Effectiveness of Recombinant Factor IX (Nonacog Alfa) in Japanese Patients With Haemophilia B
Haemophilia
Medicine
Genetics
Hematology
Highly Purified Porcine Factor VIII in Haemophilia a With Inhibitors to Factor VIII
BMJ
Psy139 - Current Use of Factor Viii Products in Children and Adolescents With Moderate or Severe Haemophilia A
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Immune Status of Patients With Haemophilia a Before Exposure to Factor VIII: First Results From the HEMFIL Study
British Journal of Haematology
Hematology
Perioperative Haemostasis With Full‐length, PEGylated, Recombinant Factor VIII With Extended Half‐life (Rurioctocog Alfa Pegol) in Patients With Haemophilia A: Final Results of a Multicentre, Single‐arm Phase III Trial
Haemophilia
Medicine
Genetics
Hematology
Is It Worthy of Switching to PegIFN Alfa-2a in Patients Achieving Virological Suppression With Entecavir?
Journal of Hepatology
Hepatology
Molecular Design and Downstream Processing of Turoctocog Alfa (NovoEight), a B-Domain Truncated Factor VIII Molecule
Blood Coagulation and Fibrinolysis
Medicine
Hematology
Drotrecogin Alfa in Patients With Severe Sepsis: Experience From a Tertiary Care Center in North India
Critical Care
Critical Care
Intensive Care Medicine
Interferon-Alfa in the Treatment of Patients With Inoperable Locally Advanced or Metastatic Renal Cell Carcinoma: A Systematic Review
Canadian Urological Association Journal
Urology
